Precision for Medicine, Oncology and Rare Disease
Precision for Medicine, Oncology and Rare Disease is the first comprehensive, fully integrated CRO devoted to oncology and rare disease combining this unique experience with Omics, big data + biomarker-guided drug development.
Precision’s uniquely integrated offering enables the science of precision medicine by combining novel clinical trial designs, industry-leading operational and medical experts, advanced biomarker solutions, and an unequivocal passion for rare diseases and oncology. We provide an uncommon array of talent and services to enable our pharmaceutical and life sciences clients to access new advancements, stay ahead of regulatory changes and ultimately achieve their goals faster. The result: a tailored pathway to approval for oncology and rare disease innovators.